Kuru: 50 lat później

• Authors: Paweł P. Liberski

Title variants

EN

Kuru: 50 years later

• Languages of publication: EN PL

Abstracts

EN

Kuru is that unique field of scientific research, in which practically everything what has been achieved, had been achieved due to personal research endeavor of Daniel Carleton Gajdusek (born in 1923), one of the greatest scientists of the XX century. In October 11-12th, John Collinge and Michael Alpers organized at the Royal Society, London, UK, a meeting “The end of kuru: 50 years of research into an extraordinary disease”. That meeting was attended by the last survivors of early kuru research, who pioneered their work in the fifties of the XX century to open a new field of “slow viruses of man”. The latter term has been introduced by Björn Sigurdsson, who developed Institute of Experimental Pathology, University of Iceland. The term “slow viruses” has been then replaced by the term “prions”. The kuru field has been already honoured by two Nobel prizes – to Dr. D.C. Gajdusek (1976 with Baruch Blumberg, born in 1925) and to Stanley B. Prusiner (1997, born in 1942) and contributed to the third – for Kurt Wüthrich (born in 1938) for “for his development of nuclear magnetic resonance spectroscopy for determining the three-dimensional structure of biological macromolecules in solution”. One of those molecules was prion protein in 1996.

PL

Kuru jest tym unikalnym obszarem badań, w którym praktycznie wszystkie osiągnięcia umożliwił osobisty wysiłek badawczy dra Daniela Carletona Gajduska (ur. w 1923 r.), jednego z największych uczonych XX wieku. John Collinge i Michael Alpers 11 i 12 października 2007 r. zorganizowali w Royal Society w Londynie sympozjum „The end of kuru: 50 years of research into an extraordinary disease”. Sympozjum to skupiło ostatnich żyjących badaczy kuru, którzy rozpoczęli swoje prace w latach pięćdziesiątych ubiegłego wieku, otwierając cały obszar badań nad „wirusami powolnymi człowieka”, pod którą to nazwą, wprowadzoną przez Bjorna Sigurdssona, założyciela Institute of Experimental Pathology, University of Iceland, kryją się obecne priony. Badania nad kuru i wirusami powolnymi człowieka i zwierząt (prionami) przyniosły już dwie nagrody Nobla - w 1976 dla D.C. Gajduska (wraz z Baruchem Blumbergiem, ur. 1925 r.) oraz w 1997 dla Stanleya B. Prusinera (ur. 1942 r.). Trzecia Nagroda Nobla także pośrednio odnosi się do wymienionych badań. Otrzymał ją Kurt Wutrich (ur. 1938 r.) za „wkład w rozwój spektroskopii magnetycznego rezonansu jądrowego dla określenia trójwymiarowej struktury makromolekuł biologicznych w roztworze”, między innymi określenia po raz pierwszy w 1996 r. struktury białka prionu.

Keywords

EN

D.C. Gajdusek; amyloid plaques; blaszki amyloidowe; kuru; neuropathology; neuropatologia; prions; priony

Discipline

• MEDICINE: MEDICINE

• Journal: Aktualności Neurologiczne
• Year: 2007
• Volume: 7
• Issue: 3
• Pages: 148-157

Contributors

author

Paweł P. Liberski

• Zakład Patologii Molekularnej i Neuropatologii Katedry Onkologii UM w Łodzi, ul. Czechosłowacka 8/10, 92-216 Łódź,

References

• 1. Gajdusek D.C., Farquhar J.: Kuru. Early Letters and Field-Notes from the Collection of D. Carleton Gajdusek. Raven Press, New York 1981.
• 2. Alpers M.P., Gajdusek D.C.: Changing pattern of Kuru: epidemiological changes in the period of increasing contact of the Fore people with western civilization. Am. J. Tropic Med. Hyg. 1965; 14: 852-879.
• 3. Alpers M.P.: Epidemiology and ecology of Kuru. W: Prusiner S.B., Hadlow WJ. (red.): Slow Transmissible Diseases of the Nervous System. Vol. 1. Academic Press, New York 1979: 67-90.
• 4. Alpers M.P.: Kuru: a Clinical Study. Mimeographed Dept. Med. Univ. Adelaide1964.
• 5. Alpers M.P.: Kuru: implications of its transmissibility for the interpretation of its changing epidemiologic pattern. W: Bailey O.T., Smith D.E. (red.): The Central Nervous System; International Academy of Pathology Monograph. No. 9. Williams & Wilkins Comp., Baltimore 1968: 234-250.
• 6. Gajdusek D.C., Reid H.L.: Studies of Kuru. IV: The Kuru pattern in Moke, a representative Fore village. Am. J. Trop. Med. Hyg. 1961; 10: 628-638.
• 7. Gajdusek D.C., Zigas V, Baker J.: Studies on Kuru. III. Patterns of Kuru incidence: demographic and geographic epidemiological analysis. Am. J. Trop. Med. Hyg. 1961: 10: 599-627.
• 8. Gajdusek D.C.: Alpers M.P., Gibbs C.J. Jr.: Kuru: epidemiological and virological studies of unique New Guinean disease with wide significance to general medicine. W: Hornabrook R.W (red.): Essays on Kuru. E.W Classey Ltd., Faringdon, Berks 1976: 125-145.
• 9. Gajdusek D.C.: Kuru in childhood: implications for the problem of whether bovine spongiform encephalopathy affects humans W: Court L., Dodet B. (red.): Transmissible subacute spongiform encephalopathies: prion disease. III International Symposium on transmissible subacute spongiform encephalopathies: prion disease. 18-20 March 1996, Val-de-Grace, Paris, France, Elsevier, Amsterdam-Oxford-Paris 1996: 15-26.
• 10. Liberski PP., Gajdusek D.C.: Kuru: forty years later. Brain Pathol. 1997; 7: 555-560.
• 11. Alpers M.P, Gajdusek D.C., Gibbs C.J. Jr: Bibliography of Kuru. Natl Inst. Health Bethesda 1975.
• 12. Lindenbaum S.: Kuru sorcery. Disease and danger in the New Guinea Highlands. Mayfield Publishing Company, Palo Alto 1979.
• 13. Goodbrand I.A., Ironside J.W, Nicolson D., Bell J.E.: Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutz-feldt-Jakob disease. Neurosci. Lett. 1995; 183: 127-130.
• 14. Mbaginta’o I.G.: Medical practices and funeral ceremony of the Dunkwi Anga. J. Soc. Ocean 1976; 32: 299-305.
• 15. GajdusekD.C., Zigas V: Kuru. Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Papua. Am. J. Med. 1959; 26: 442-469.
• 16. Beck E., Daniel PM., Alpers M.P i wsp.: Neuropathological comparisons of experimental kuru in Chimpanzees with human kuru. With a note on its relation to scrapie and spongiform encephalopathy. W: Burdzy K., Kallos P (red.): Pathogenesis and Etiology of Demyelinating Diseases. Proc. of the Workshop on Contributions to the Pathogenesis and Etiology of Demylinating Conditions, Locarno, Switzerland, May 31st-June 3rd, 1967, Additamentum to Arch. Allergy Appl. Immunol. 1969, Vol. 36, Karger S., Basel: 553-562.
• 17. Beck E., Daniel P.M.: Kuru and Creutzfeldt-Jakob disease: neuropathological lesions and their significance. W: Prusiner S.B., Hadlow WJ. (red.): Slow Transmissible Diseases of the Nervous System. Vol. 1. Academic Press, New York 1979: 253-270.
• 18. Gajdusek D.C., Gibbs C.J., Alpers M.P: Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966; 209: 794-796.
• 19. Gajdusek D.C.: Kuru: an appraisal of five years of investigation. Eugen. Q. 1962; 9: 69-74.
• 20. Gajdusek D.C., Gibbs C.J. Jr., Alpers M.: Slow Latent and Temperate Virus Infections. US Department of Health, Education and Welfare, National Institute of Health. Bethesda 1965.
• 21. Kitchin D., Bearn A.G., Alpers M.P, Gajdusek D.C.: Genetic studies in relation to Kuru. III. Distribution of the inherited serum group-specific protein (Gc) phenotypes in New Guineans: an association of Kuru and the Gc Ab phenotype. Am. J. Hum. Gen. 1972; 24: 72-85.
• 22. Prusiner S.B., Gajdusek C., Alpers M.P: Kuru with incubation periods exceeding two decades. Ann. Neurol. 1982; 12: 1-9.
• 23. Simmons R.T, Graydon J.J., Gajdusek D.C. i wsp.: Genetic studies in relation to Kuru. II. Blood-group genetic patterns and populations of the eastern Highlands of New Guinea. Am. J. Hum. Gen. 1972; 24: S39-S71.
• 24. Simmons R.T., Graydon J.J., Zigas V. i wsp.: Studies on Kuru. V. A blood group genetical survey of the Kuru region and other parts of Papua New Guinea. Am. J. Trop. Med. Hyg. 1961; 10: 639-664.
• 25. Simmons R.T., Graydon J.J., Zigas V. i wsp.: Studies on Kuru. VI. Blood groups in Kuru. Am. J. Trop. Med. Hyg. 1961; 10: 665-668.
• 26. GajdusekD.C.: Kuru and scrapie. W: Prusiner S.B. iwsp. (red.): Prion Diseases of Humans and Animals. Ellis Hor-wood, New York, London, Toronto, Sydney, Singapore 1993.
• 27. Hadlow WJ.: Scrapie and kuru. Lancet 1959; 2: 289-290.
• 28. Fowler M., Robertson E.G.: Observations on Kuru. III: pathological features in five cases. Australasian Ann. Med. 1959; 8: 16-26.
• 29. Hornabrook R.W: Kuru and clinical neurology. W: Prusiner S.B., Hadlow WJ. (red.): Slow Transmissible Diseases of the Nervous System. Academic Press, New York 1979: 37-66.
• 30. Hainfellner J.A., Liberski EE, Guiroy D.C. i wsp.: Pathology and immunocytochemistry of a kuru brain. Brain Pathol. 1997; 7: 547-554.
• 31. Klatzo I., Gajusek D.C., Zigas V: Evaluation of pathological findings in twelve cases of kuru. W: Van Boagert L. iwsp. (red.): Encephalitides. Elsevier Publ. Comp., Amsterdam 1959: 172-190.
• 32. Klatzo I., Gajusek D.C.: Pathology of kuru. Lab. Invest. 1959; 8: 799-847.
• 33. Lantos P, Bhatia K., Doey L.J. i wsp.: Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar. Lancet 1997; 350: 187-188.
• 34. Simpson D.A., Lander H., Robson H.N.: Observations on Kuru. II. Clinical features. Aust. Ann. Med. 1959; 8: 8-15.
• 35. Wilson K., Zigas V, Gajdusek D.C.: New tremor syndromes occurring sporadically in natives of the Wabag-Laiagam-Kundep region of the Western Highlands of Australian New Guinea. Lancet 1959; 2: 699-702.
• 36. Beck E., Daniel P.M., Alpers M. i wsp.: Experimental “kuru” in chimpanzees. A pathological report. Lancet 1966; 2: 1056-1059.
• 37. Beck E., Daniel P.M., Asher D.M. i wsp.: Experimental kuru in chimpanzee: A neuropathological study. Brain 1973; 96: 31-38.
• 38. Beck E., Daniel PM.: Kuru and scrapie compared: are they examples of system degeneration? W: Gajdusek D.C., Gibbs C.J. Jr., Alpers M.P (red.): Slow, Latent, and Temperate Virus Infections. U.S. Dept. Health, Education, Welfare, Washington, D.C. 1965: 85-93.
• 39. Beck E., Daniel P.M.: Neuropathology of transmissible spongiform encephalopathies. W: Prusiner S.B., McKinley M.P. (red.): Prions. Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Academic Press, New York 1987: 331-386.
• 40. Masters C.L., Gajdusek D.C.: The spectrum of Creutz-feldt-Jakob disease and the virus induced subacute spongiform encephalopathies. W: Smith TJ., Cavanagh J.B. (red.): Recent Advances in Neuropathology. Churchill Livingstone, Edinburgh 1982: 139-163.
• 41. Neuman M.A., Gajdusek D.C., Zigas V: Neuropathologic findings in exotic neurologic disorder among natives of the Highlands of New Guinea. J. Neuropathol. Exp. Neurol. 1964; 23: 486-507.
• 42. Guiroy D.C., Wakayama I., Liberski PP. i wsp.: Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerst-mann-Straussler syndrome. Acta Neuropathol. (Berl.) 1994; 87: 526-530.
• 43. Piccardo P, Safar J., Ceroni M. i wsp.: Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue. Neurology 1990; 40: 518-522.
• 44. Guiroy D.C., Liberski PP, Papierz W, Gajdusek D.C.: Amyloid beta-protein present in brain amyloid of a 32-year old with progressive dementia. Acta Neuropathol. (Berl.) 1991; 82: 523-526.
• 45. Beck E., Bak I.J., Christ J.F. i wsp.: Experimental kuru in the Spider monkey. Histopathological and ultrastructural studies of the brain during early stages of incubation. Brain 1975; 98: 595-612.
• 46. Ironside J.: Neuropathological diagnosis of human prion disease. W: Baker H., Ridley R.M. (red.): Methods in Molecular Medicine: Prion Diseases. Humana Press Inc., To-towa, N.J. 1996: 35-57.
• 47. Ironside J.W, Bell J.B.: Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet 1997; 350: 1475.
• 48. McLean C.A., Ironside J.W, Alpers M.P i wsp.: Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol. 1998; 8: 428-437.
• 49. Will R.G., Ironside J.W, Zeidler M. i wsp.: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996: 347: 921-925.
• 50. Barcikowska M., Liberski P.P., Boellaard J. i wsp.: Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Straussler-Scheinker syndrome. Acta Neuropathol. (Berl.) 1993; 85: 623-627.
• 51. Glasse R., Lindenbaum S.: Fieldwork in the South Fore: the process of ethnographic inquiry. W: Prusiner S.B. i wsp. (red.): Prion Diseases of Humans and Animals. Ellis Horwood, New York, London, Toronto, Sydney, Singapore 1993: 77-91.

• Document Type: article